NCT01910259 MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial Status COMPLETED Phase PHASE2
NCT01907295 National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension Status UNKNOWN Phase N/A
NCT01882452 A Randomised Controlled Clinical Trial of Memory Specificity Training (MEST) for Depression Status COMPLETED Phase NA
NCT01847716 Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension Status TERMINATED Phase N/A
NCT01827579 Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT) Status COMPLETED Phase PHASE1/PHASE2
NCT01825031 Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy Status COMPLETED Phase PHASE3
NCT01815632 Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) Status UNKNOWN Phase PHASE2
NCT01802385 Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis Status COMPLETED Phase PHASE3
NCT01785186 Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design Status COMPLETED Phase PHASE2
NCT01697007 A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique Status COMPLETED Phase PHASE2
NCT01653665 Does GM-CSF Restore Neutrophil Phagocytosis in Critical Illness? Status COMPLETED Phase PHASE1/PHASE2
NCT01650389 Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination Status COMPLETED Phase PHASE2
NCT01641016 BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection Status UNKNOWN Phase PHASE2/PHASE3
NCT01570946 Use of Mobile Technology to Promote Sustained Lifestyle Changes to Prevent Type 2 Diabetes in India and the UK Status COMPLETED Phase NA